Skip to main content

Table 3 Polysomnographic characteristics for all cardiometabolic comorbidities

From: Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality

 

Diabetes

n = 386

No diabetes

n = 1331

p value

CVCo

n = 671

No CVCo n = 1046

p value

Dyslipidemia n = 453

No dyslipidemia n = 1253

p value

AHI

45.82 ± 25.77

42.23 ± 25.60

0.0156

43.58 ± 24.59

42.50 ± 26.85

NS

44.12 ± 24.31

42.66 ± 26.18

NS

AHI/REM

50.01 ± 27.29

48.38 ± 26.99

NS

49.80 ± 26.77

47.61 ± 27.32

NS

47.53 ± 26.22

49.19 ± 27.34

NS

AHI/NREM

41.73 ± 26.26

38.46 ± 26.87

0.0342

39.40 ± 25.48

39.03 ± 28.13

NS

40.39 ± 25.19

38.79 ± 27.33

NS

SL (min)

70.01 ± 62.26

73.20 ± 62.06

NS

70.05 ± 59.99

75.20 ± 64.20

NS

68.20 ± 60.82

74.11 ± 62.48

NS

SE (%)

63.61 ± 15.05

67.42 ± 14.57

0.0001

64.89 ± 14.94

68.30 ± 14.45

0.0001

64.65 ± 14.65

67.21 ± 14.80

0.0022

TST (min)

327.12 ± 78.35

343.64 ± 76.60

0.0002

331.59 ± 79.02

348.56 ± 74.81

0.0001

330.79 ± 79.06

343.04 ± 76.64

0.0052

N1 (%)

4.55 ± 4.56

4.13 ± 3.62

NS

4.56 ± 4.27

3.90 ± 3.39

0.0156

4.92 ± 4.74

3.99 ± 3.48

<0.0001

N2 (%)

50.88 ± 16.37

50.36 ± 15.89

NS

50.61 ± 15.50

50.40 ± 16.50

NS

51.27 ± 15.81

50.22 ± 16.03

NS

N3 (%)

29.11 ± 17.19

28.67 ± 15.79

NS

28.80 ± 15.81

28.69 ± 16.41

NS

27.77 ± 16.28

29.10 ± 16.01

NS

REM (%)

15.52 ± 7.32

16.91 ± 6.88

0.0006

16.16 ± 7.29

17.04 ± 6.65

0.0091

16.17 ± 7.34

16.72 ± 7.34

NS

ARI

39.91 ± 18.34

37.13 ± 17.94

0.0007

37.91 ± 17.04

37.67 ± 19.14

NS

39.39 ± 17.55

37.20 ± 17.55

0.0356

Mean duration

AH REM (sec)

25.59 ± 11.00

26.36 ± 9.69

NS

26.46 ± 10.41

25.89 ± 9.56

NS

27.09 ± 11.68

25.83 ± 11.68

0.0429

Mean duration

AH NREM (sec)

21.90 ± 6.02

22.41 ± 5.96

NS

22.32 ± 5.73

22.24 ± 6.24

NS

22.63 ± 6.17

22.15 ± 6.17

NS

PLM

6.31 ± 22.47

5.63 ± 16.80

NS

6.23 ± 18.97

5.26 ± 17.33

NS

5.87 ± 19.18

5.73 ± 17.83

NS

ODI

57.42 ± 32.30

45.37 ± 30.60

<0.0001

50.44 ± 30.42

45.79 ± 32.36

0.0357

50.28 ± 31.87

47.60 ± 31.87

NS

Mean 02 saturation

TST (%)

92.81 ± 30.94

92.18 ± 2.67

NS

92.27 ± 20.47

92.35 ± 2.75

NS

91.54 ± 2.88

92.59 ± 2.88

NS

02 desaturation

< 90% (min)

102.33 ± 115.04

74.44 ± 99.13

<0.0001

91.67 ± 108.71

69.54 ± 97.24

<0.0001

96.06 ± 113.31

75.47 ± 113.31

0.0005

Minimal 02

saturation (%)

75.14 ± 10.42

77.58 ± 9.41

<0.0001

76.43 ± 9.64

77.62 ± 9.83

0.0203

76.20 ± 9.78

77.28 ± 9.78

NS

Mean HR (beats/min)

70.78 ± 10.36

68.10 ± 9.95

<0.0001

67.88 ± 10.25

69.63 ± 9.85

0.0003

68.20 ± 10.20

69.91 ± 10.20

NS

  1. AHI Apnea-hypopnea index, AH Apnea-hypopnea, REM Rapid eye movement sleep, NREM Non-rapid eye movement sleep, CVCo Cardiovascular Comorbidities, SL Sleep latency, TST Total sleep time, SE Sleep efficiency, N1 Sleep stage 1, N2 Sleep stage 2, N3 Sleep stage 3, PLM Periodic leg movements index, ODI Oxygen desaturation index, ARI Arousal index, 02 Oxygen, HR: heart rhythm. All the results are expressed as Mean + SD. NS: not significant
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us